Eli Lilly Begins Clinical Trial for COVID-19 Therapies

Eli Lilly and Co. reports it has begun clinical trials for testing therapies for COVID-19. The drug company said it has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes …

from News – Insurance Journal